Remove Ethics Remove Fixed Costs Remove Industry Remove Price
article thumbnail

Solving the $100,000 Cancer Drug Problem

Harvard Business Review

Last week over 100 leading cancer specialists signed their names to an op-ed in Blood , the journal of the American Society of Hematology, which lambasted the prices of cancer drugs that often exceed $100,000 annually. While pharma companies spend billions on research, the actual cost of manufacturing a treatment (such as a pill) is minimal.

article thumbnail

Why Tesco’s Strengths Are No Longer Good Enough

Harvard Business Review

It provides consumers with a viable, lower cost alternative to the manufacturer branded products. Tesco came to the party much later in the 1980s but ended up winning with its “good-better-best” private label lines, setting the industry standard for how to play the private label game. Aldi offers not just low prices, but convenience.

Retail 10